A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of thalidomide in the treatment of refractory uremic pruritus in maintenance hemodialysis patients.

Clinical Trial Description

A prospective, randomized, double-blind, placebo-controlled study was conducted to explore the efficacy and safety of thalidomide in the treatment of refractory urmia pruritus. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05525234
Study type	Interventional
Source	RenJi Hospital
Contact	Renhua Lu, Doctor
Phone	86-13361958582
Email	lurenhua1977@hotmail.com
Status	Not yet recruiting
Phase	Phase 4
Start date	September 15, 2022
Completion date	January 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04728984` - A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet	Phase 3
Completed	`NCT02143973` - Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus	Phase 2/Phase 3
Terminated	`NCT01660243` - Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis	Phase 2
Completed	`NCT06159686` - The Efficacy of Hemp-containing Cream Versus Placebo in the Treatment of Uremic Pruritus	Phase 1/Phase 2
Completed	`NCT03002233` - TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus	Phase 1
Completed	`NCT03998163` - CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus	Phase 3
Active, not recruiting	`NCT05885737` - Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus	Phase 3
Recruiting	`NCT04393675` - Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients	Phase 1/Phase 2
Completed	`NCT03576235` - Safety and Efficacy of PG102P for Uremic Pruritus in HD Patients	N/A
Completed	`NCT05575193` - Acupressure on Uremic Pruritus and Sleep Quality Among Patients Receiving Hemodialysis	N/A
Completed	`NCT02858726` - Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus	Phase 2/Phase 3
Completed	`NCT02143648` - Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus	Phase 2/Phase 3
Completed	`NCT00494975` - The Effect of Phototherapy on Pruritus of Patients With Chronic Kidney Disease	N/A
Recruiting	`NCT06446310` - Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus	Phase 3
Completed	`NCT03758079` - Comparison of Gabapentin With Doxepin in the Management of Uremic Pruritus	Phase 4
Completed	`NCT02229929` - Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus	Phase 2
Completed	`NCT04639674` - AST-120 in Hemodialysis Patients With Uremic Pruritus	Phase 4
Completed	`NCT03636269` - CR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus	Phase 3
Not yet recruiting	`NCT06466421` - Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis	Phase 4
Completed	`NCT04711603` - A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.	Phase 3